The prognostic significance of the triple negative phenotype in endometrial cancer

Cancer Statistics, 2009

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype

Katrina Bauer, Monica Brown, Rosemary D. Cress et al. · Cancer · 2007 · 2.1K citations

Medicine, Oncology, Breast Oncology +11

The epidemiology of triple-negative breast cancer, including race

Katrina F. Trivers, Mary Jo Lund, Peggy L. Porter et al. · Cancer Causes & Control · 2009 · 340 citations · Full text

Medicine, Biostatistics, Oncology +10

HER-2 Is an Independent Prognostic Factor in Endometrial Cancer: Association With Outcome in a Large Cohort of Surgically Staged Patients

Carl Morrison, Vanna Zanagnolo, Nilsa C. Ramirez et al. · Journal of Clinical Oncology · 2006 · 254 citations

Medicine, Oncology, Pathology +8

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

Joyce O’Shaughnessy, Cynthia R. Osborne, John Pippen et al. · Journal of Clinical Oncology · 2009 · 243 citations

Medicine, Oncology, Pharmacology +17